Literature DB >> 12444981

Rodent alpha-chymases are elastase-like proteases.

Yuichi Kunori1, Masahiro Koizumi, Tsukio Masegi, Hidenori Kasai, Hiroshi Kawabata, Yuzo Yamazaki, Akiyoshi Fukamizu.   

Abstract

Although the alpha-chymases of primates and dogs are known as chymotrypsin-like proteases, the enzymatic properties of rodent alpha-chymases (rat mast cell protease 5/rMCP-5 and mouse mast cell protease 5/mMCP-5) have not been fully understood. We report that recombinant rMCP-5 and mMCP-5 are elastase-like proteases, not chymotrypsin-like proteases. An enzyme assay using chromogenic peptidyl substrates showed that mast cell protease-5s (MCP-5s) have a clear preference for small aliphatic amino acids (e.g. alanine, isoleucine, valine) in the P1 site of substrates. We used site-directed mutagenesis and computer modeling approaches to define the determinant residue for the substrate specificity of mMCP-5, and found that the mutant possessing a Gly substitution of the Val at position 216 (V216G) lost elastase-like activity but acquired chymase activity, suggesting that the Val216 dominantly restricts the substrate specificity of mMCP-5. Structural models of mMCP-5 and the V216G mutant based on the crystal structures of serine proteases (rMCP-2, human cathepsin G, and human chymase) revealed the active site differences that can account for the marked differences in substrate specificity of the two enzymes between elastase and chymase. These findings suggest that rodent alpha-chymases have unique biological activity different from the chymases of other species.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444981     DOI: 10.1046/j.1432-1033.2002.03316.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  28 in total

1.  The inflammatory response after an epidermal burn depends on the activities of mouse mast cell proteases 4 and 5.

Authors:  George Younan; Freeman Suber; Wei Xing; Tong Shi; Yuichi Kunori; Magnus Abrink; Gunnar Pejler; Susan M Schlenner; Hans-Reimer Rodewald; Francis D Moore; Richard L Stevens; Roberto Adachi; K Frank Austen; Michael F Gurish
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

Review 2.  Chymase inhibition as a pharmacological target: a role in inflammatory and functional gastrointestinal disorders?

Authors:  S Heuston; N P Hyland
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

3.  Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents.

Authors:  Chih-Chang Wei; Naoki Hase; Yukiko Inoue; Eddie W Bradley; Eiji Yahiro; Ming Li; Nawazish Naqvi; Pamela C Powell; Ke Shi; Yoshimasa Takahashi; Keijiro Saku; Hidenori Urata; Louis J Dell'italia; Ahsan Husain
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

Review 4.  Mast cell tryptases and chymases in inflammation and host defense.

Authors:  George H Caughey
Journal:  Immunol Rev       Date:  2007-06       Impact factor: 12.988

5.  Experimental Arthritis Is Dependent on Mouse Mast Cell Protease-5.

Authors:  Richard L Stevens; H Patrick McNeil; Lislaine A Wensing; Kichul Shin; G William Wong; Philip M Hansbro; Steven A Krilis
Journal:  J Biol Chem       Date:  2017-02-13       Impact factor: 5.157

6.  Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism.

Authors:  Katherine R Groschwitz; Richard Ahrens; Heather Osterfeld; Michael F Gurish; Xiaonan Han; Magnus Abrink; Fred D Finkelman; Gunnar Pejler; Simon P Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-16       Impact factor: 11.205

7.  A Pulmonary Perspective on GASPIDs: Granule-Associated Serine Peptidases of Immune Defense.

Authors:  George H Caughey
Journal:  Curr Respir Med Rev       Date:  2006-08

Review 8.  Mast cell peptidases: chameleons of innate immunity and host defense.

Authors:  Neil N Trivedi; George H Caughey
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-20       Impact factor: 6.914

9.  Mast cell and neutrophil peptidases attack an inactivation segment in hepatocyte growth factor to generate NK4-like antagonists.

Authors:  Wilfred W Raymond; Anthony C Cruz; George H Caughey
Journal:  J Biol Chem       Date:  2005-11-22       Impact factor: 5.157

Review 10.  Mast cell proteases as pharmacological targets.

Authors:  George H Caughey
Journal:  Eur J Pharmacol       Date:  2015-05-07       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.